| 4985- | ATV, | Dipy, | Repurposing of the Cardiovascular Drug Statin for the Treatment of Cancers: Efficacy of Statin-Dipyridamole Combination Treatment in Melanoma Cell Lines |
| - | in-vivo, | Melanoma, | SK-MEL-28 | - | in-vitro, | BC, | MDA-MB-435 |
| 4986- | ATV, | Dipy, | The combination of statins and dipyridamole is effective preclinically in AML, MM, and breast cancer |
| - | Review, | Var, | NA |
| 1302- | AV, | Quantitative measurement of Bax and Bcl2 genes and protein expression in MCF7 cell-line when treated by Aloe Vera extract |
| - | in-vitro, | BC, | MCF7 |
| 5368- | AV, | Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms |
| - | Trial, | HNSCC, | NA |
| 5362- | AV, | Anti-cancer effects of aloe-emodin: a systematic review |
| - | Review, | Var, | NA |
| 5363- | AV, | Exploring the mechanism of aloe-emodin in the treatment of liver cancer through network pharmacology and cell experiments |
| - | Study, | HCC, | NA |
| 5364- | AV, | A New Biomaterial Derived from Aloe vera—Acemannan from Basic Studies to Clinical Application |
| - | Review, | Var, | NA |
| 5365- | AV, | Aloe Vera Polysaccharides as Therapeutic Agents: Benefits Versus Side Effects in Biomedical Applications |
| - | Review, | Nor, | NA | - | Review, | IBD, | NA | - | Review, | Diabetic, | NA |
| 5366- | AV, | Aloe vera: A review of toxicity and adverse clinical effects |
| - | Review, | Var, | NA |
| 5367- | AV, | Rad, | Aloe vera for prevention of radiation-induced dermatitis: a self-controlled clinical trial |
| - | Trial, | Var, | NA |
| 5369- | AV, | Assessment of Anticancer Effects of Aloe vera on 3D Liver Tumor Spheroids in a Microfluidic Platform |
| - | in-vitro, | Liver, | HepG2 |
| 5370- | AV, | The Effect of Aloe Vera Solution on Chemotherapy-Induced Stomatitis in Clients with Lymphoma and Leukemia: A Randomized Controlled Clinical Trial |
| - | Trial, | AML, | NA |
| 5371- | AV, | Assessment of the immunomodulatory effect of Aloe vera polysaccharides extracts on macrophages functions |
| - | Study, | Nor, | NA |
| 5581- | B-Gluc, | Chemo-Immunotherapy Using Lentinan for the Treatment of Gastric Cancer with Liver Metastases |
| - | Human, | GC, | NA |
| 5572- | B-Gluc, | The Effects of Orally Administered Beta-Glucan on Innate Immune Responses in Humans, a Randomized Open-Label Intervention Pilot-Study |
| - | Study, | Nor, | NA |
| 5571- | B-Gluc, | immuno, | Potential benefit of β-glucans as adjuvant therapy in immuno-oncology: a review |
| - | Review, | Var, | NA |
| 5570- | B-Gluc, | Immunomodulation of Fungal β-Glucan in Host Defense Signaling by Dectin-1 |
| - | Review, | Var, | NA |
| 5569- | B-Gluc, | Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine response |
| - | in-vitro, | CRC, | NA |
| 5568- | B-Gluc, | immuno, | Beta-glucans in oncology: revolutionizing treatment with immune power & tumor targeting |
| - | Review, | Var, | NA |
| 5567- | B-Gluc, | Trained immunity: A new player in cancer immunotherapy |
| - | Review, | Var, | NA |
| 5566- | B-Gluc, | The effects of beta-glucan on human immune and cancer cells |
| - | Review, | Var, | NA |
| 5573- | B-Gluc, | Continuous Exposure to Non-Soluble β-Glucans Induces Trained Immunity in M-CSF-Differentiated Macrophages |
| - | in-vitro, | Nor, | NA |
| 5574- | B-Gluc, | Beta Glucan: Health Benefits in Obesity and Metabolic Syndrome |
| - | Review, | Obesity, | NA |
| 5575- | B-Gluc, | The effects of β-glucan on human immune and cancer cells |
| - | Review, | Var, | NA |
| 5576- | B-Gluc, | Chemo, | Lentinan prolonged survival in patients with gastric cancer receiving S-1-based chemotherapy |
| - | Trial, | GC, | NA |
| 5577- | B-Gluc, | Lentinan progress in inflammatory diseases and tumor diseases |
| - | Review, | Var, | NA | - | Review, | IBD, | NA |
| - | Trial, | GC, | NA |
| 5579- | B-Gluc, | Fungal beta-glucans as adjuvants for treating cancer patients – A systematic review of clinical trials |
| - | Review, | Var, | NA |
| 5580- | B-Gluc, | Lentinan, a Shiitake Mushroom β-Glucan, Downregulates the Enhanced PD-L1 Expression Induced by Platinum Compounds in Gastric Cancer Cells |
| - | in-vitro, | GC, | MKN45 |
| 874- | B-Gluc, | Potential promising anticancer applications of β-glucans: a review |
| - | Review, | NA, | NA |
| 875- | B-Gluc, | Chemistry, physico-chemistry and applications linked to biological activities of β-glucans |
| - | Review, | NA, | NA |
| 876- | B-Gluc, | Clinical and Physiological Perspectives of β-Glucans: The Past, Present, and Future |
| - | Review, | NA, | NA |
| 996- | Ba, | Tam, | Baicalein resensitizes tamoxifen‐resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia‐inducible factor‐1α |
| 999- | Ba, | Baicalin Inhibits EMT through PDK1/AKT Signaling in Human Nonsmall Cell Lung Cancer |
| - | in-vitro, | Lung, | H460 |
| 6- | Ba, | Api, | QC, | Common Botanical Compounds Inhibit the Hedgehog Signaling Pathway in Prostate Cancer |
| - | in-vitro, | Pca, | PC3 |
| 1029- | Ba, | BA, | Baicalein and baicalin promote antitumor immunity by suppressing PD-L1 expression in hepatocellular carcinoma cells |
| - | vitro+vivo, | HCC, | NA |
| 1098- | BA, | Baicalein inhibits fibronectin-induced epithelial–mesenchymal transition by decreasing activation and upregulation of calpain-2 |
| - | in-vitro, | Nor, | MCF10 | - | in-vivo, | NA, | NA |
| - | in-vivo, | BC, | 4T1 |
| 5508- | Ba, | Neuroprotective effects of baicalin and baicalein on the central nervous system and the underlying mechanisms |
| - | Review, | Stroke, | NA | - | Review, | Park, | NA | - | Review, | AD, | NA |
| 5498- | Ba, | Inhibition of 12-lipoxygenase during baicalein-induced human lung nonsmall carcinoma H460 cell apoptosis |
| - | in-vitro, | Lung, | H460 |
| 5507- | Ba, | Baicalein Enhances Radiosensitivity in Colorectal Cancer via JAK2/STAT3 Pathway Inhibition |
| - | vitro+vivo, | Var, | NA |
| 5506- | Ba, | Improved Bioavailability and Hepatoprotective Activity of Baicalein Via a Self-assembled Solutol HS15 Micelles System |
| - | in-vivo, | Nor, | NA |
| 5505- | Ba, | Baicalein inhibits the progression of thyroid cancer by suppressing the TPL2/MEK2/ERK2 pathway |
| - | in-vitro, | Thyroid, | NA |
| - | in-vivo, | Nor, | NA |
| 5503- | Ba, | Preparation, pharmacokinetics and biodistribution of baicalin-loaded liposomes |
| - | Study, | Nor, | NA |
| 5502- | Ba, | An overview of pharmacological activities of baicalin and its aglycone baicalein: New insights into molecular mechanisms and signaling pathways |
| - | Review, | Var, | NA |
| 5501- | Ba, | Therapeutic effects and mechanisms of action of Baicalein on stomach cancer: a comprehensive systematic literature review |
| - | Review, | GC, | NA |
| 5500- | Ba, | Safety, tolerability, and pharmacokinetics of oral baicalein tablets in healthy Chinese subjects: A single‐center, randomized, double‐blind, placebo‐controlled multiple‐ascending‐dose study |
| - | Trial, | Nor, | NA |
| 5499- | Ba, | Anti-cancer effects of baicalein in non-small cell lung cancer in-vitro and in-vivo |
| - | vitro+vivo, | Lung, | H460 | - | vitro+vivo, | Lung, | A549 |
| 5497- | Ba, | Role of Intestinal Microbiota in Baicalin-Induced Drug Interaction and Its Pharmacokinetics |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid